Is DKNG a buy, hold, or sell?
DKNG carries a valuation grade of Hold. The trailing P/E of 292.1 sits 1024% above the Consumer Cyclical sector median of 26.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $19–$62 — implying a +54% margin of safety at the current price of $26.29. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 3% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 16.4% earnings surprise. Analyst estimate revisions are trending upward.
What are DKNG's key risk factors?
With a beta of 1.64, DKNG exhibits a highly aggressive risk profile relative to the broad market. The 95th-percentile CVaR of -35.8% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 3.6% of total portfolio loss in the worst 5% of months. Net margins of 0.9% fall below the Consumer Cyclical sector average of 10%, suggesting margin pressure. Debt-to-equity of 317% warrants monitoring for leverage risk.
At 0.44, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 57.4% is below realized volatility of 73.1%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $73.5M recently. While routine dispositions are common, the magnitude bears watching. Short interest stands at 8.4% of float, a moderate level.
How does DKNG fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — DKNG carries a beta of 1.64, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, DKNG shows the strongest co-movement with FLUT (0.69), BKNG (0.26), DIS (0.25). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The DKNG analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning DKNG’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
